5-(trifluoromethyl)-2-pyridyl 3-methyl-5-(trifluoromethyl)isoxazole-4-carbothioate

Catalog No. :
ACWXXT160
CAS No. :
256488-21-8
Molecular Formula :
C12H6F6N2O2S
Molecular Weight :
356.25

IUPAC Name:O-(5-(trifluoromethyl)pyridin-2-yl) 3-methyl-5-(trifluoromethyl)isoxazole-4-carbothioate

5-(trifluoromethyl)-2-pyridyl 3-methyl-5-(trifluoromethyl)isoxazole-4-carbothioate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(trifluoromethyl)-2-pyridyl 3-methyl-5-(trifluoromethyl)isoxazole-4-carbothioate
IUPAC NameO-(5-(trifluoromethyl)pyridin-2-yl) 3-methyl-5-(trifluoromethyl)isoxazole-4-carbothioate
MDL No.MFCD00113872
Molecular FormulaC12H6F6N2O2S
Molecular Weight356.25
SMILESS=C(C1=C(C(F)(F)F)ON=C1C)OC2=NC=C(C(F)(F)F)C=C2
InChI KeyASOBVSJRQPNDQA-UHFFFAOYSA-N
Synonym4-Isoxazolecarbothioic acid, 3-methyl-5-(trifluoromethyl)-, S-[5-(trifluoromethyl)-2-pyridinyl] ester
CAS No.256488-21-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWXXT160 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPVGH896 route compound structure diagram
    ACPVGH89633252-63-0 In Stock
  4. Then
  5. ACWXXT160 route product structure diagram
    ACWXXT160256488-21-8
Inquiry

2. ACWXXT160 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPVGH896 route compound structure diagram
    ACPVGH89633252-63-0 In Stock
  4. Then
  5. ACWXXT160 route product structure diagram
    ACWXXT160256488-21-8
Inquiry

Comments (0)